Keyphrases
Ultraviolet-B (UV-B)
100%
Israel
73%
Cutaneous Leishmaniasis
64%
Mycosis Fungoides
63%
Narrowband UVB
56%
Psoriasis
49%
Atopic Dermatitis
38%
Melanoma
38%
Sodium Stibogluconate
35%
Liposomal Amphotericin B
31%
Phototherapy
31%
Complete Response
31%
Tumor
30%
Jewish
29%
Malignant Melanoma
29%
Leishmania Tropica
29%
Israeli
25%
Outdoor Workers
24%
Melanoma Risk
24%
Risk Factors
23%
Retrospective Cohort Study
23%
Leishmania Major
23%
Psoralen Plus Ultraviolet A
23%
Travellers
21%
Metastatic Melanoma
21%
Sun Exposure
20%
Neural Systems
19%
Rituximab
19%
Serum Levels
19%
25-hydroxyvitamin D3
19%
Sun Protection
19%
Melanocytic Nevus
19%
Nevus
19%
Photochemotherapy
19%
Pediatric Psoriasis
19%
Leishmania Braziliensis
19%
Systemic Treatment
19%
Melanoma Patients
18%
25(OH)D3
17%
CDKN2A mutation
17%
Retrospective Analysis
17%
Odds Ratio
17%
Pancreatic Cancer
16%
Pemphigus Vulgaris
14%
Narrowband Ultraviolet B Phototherapy
14%
Cyclin-dependent Kinase 4 (CDK4)
14%
Immunoglobulin E
14%
Psoriatic Patients
14%
Treatment Response
14%
Medical Center
14%
Medicine and Dentistry
Nodular Melanoma
74%
Mycosis fungoides
69%
Phototherapy
50%
Disease
49%
Cutaneous Leishmaniasis
47%
Psoriasis
41%
Psoralen
33%
Atopic Dermatitis
32%
Lichen Planus
29%
Neoplasm
26%
Sodium Stibogluconate
24%
Systemic Therapy
23%
Nevus Sebaceous
23%
Retrospective Cohort Study
22%
Skin Cancer
22%
Melanocytic Nevus
21%
Leishmania Major
21%
PUVA
20%
Photochemotherapy
19%
Sun Protection
19%
Rituximab
19%
Leishmania tropica
19%
Sun Exposure
17%
Retrospective Study
17%
Vitiligo
16%
Sunscreen
14%
Lentigo
14%
Side Effect
13%
Odds Ratio
13%
Pemphigus vulgaris
13%
Infection
13%
Amphotericin B
13%
Inflammatory Disorder
12%
Adolescent
12%
Pancreas Cancer
12%
Malignant Neoplasm
12%
Pediatrics
11%
Quality of Life
11%
Prevalence
11%
Treatment Response
11%
Cutaneous T Cell Lymphoma
11%
Skin Type
10%
Neural System
9%
Disease Course
9%
Bullous Pemphigoid
9%
Gene Mutation
9%
Torticollis
9%
Antibody Response
9%
Immigrant
9%
Pityriasis lichenoides
9%